Abstract
One of the promising opportunities of digital health is its potential to lead to more holistic understandings of diseases by interacting with the daily life of patients and through the collection of large amounts of real world data. Validating and benchmarking indicators of disease severity in the home setting is difficult, however, given the large number of confounders present in the real world and the challenges in collecting ground truth data in the home. Here we leverage two datasets with continuous wrist-worn accelerometer data coupled with frequent symptom reports in the home setting, to develop digital biomarkers of symptom severity. Using these data, we performed a public benchmarking challenge in which participants were asked to build measures of severity across 3 symptoms (on/off medication, dyskinesia, and tremor). 42 teams participated and performance was improved over baseline models for each subchallenge. Additional ensemble modeling across submissions further improved performance, and the top models validated in a subset of patients whose symptoms were observed and rated by trained clinicians.
Competing Interest Statement
YG serves as scientific advisor for Eli Lilly and Company and Merck & Co.; serves as scientific advisor and receives grants from Merck KGaA. YH has grant funding through BBJ from Sanofi S.A. and UCB for unrelated projects. BBJ has grant funding from Sanofi S.A. and UCB for unrelated projects. AJ is funded by MJ Fox Foundation for data curation. All other authors report no competing interests.
Funding Statement
The BEAT-PD Challenge was funded by the Michael J. Fox Foundation. The ensemble computations were partly enabled by Scientific Computing resources at the Icahn School of Medicine at Mount Sinai, and YL and GP were supported by NIH R01HG011407-01A1. YG is funded by the Michael J. Fox Foundation. BKBJ was supported by a grant from NIH NINDS (award #: K99NS114850). MSK is supported by a grant from NIH (award #: 5T32HG002295-18). CSV, GS, and RZ received research support funded by the NIH NINDS under award number P50NS108676.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
CIS-PD was sponsored by the Michael J. Fox Foundation for Parkinson's Research and conducted across four US sites: Northwestern University, the University of Cincinnati, the University of Rochester, and the University of Alabama at Birmingham. Each site had local Institutional Review Board (IRB)/Research Ethics Board (REB) approval, and all participants signed informed consent. REAL-PD was sponsored by the Michael J. Fox Foundation for Parkinson's Research. The study protocol was approved by the local medical ethics committee (Commissie Mensgebonden Onderzoek, region Arnhem-Nijmegen, the Netherlands, file number 2016-1776). All participants received verbal and written information about the study protocol and signed a consent form prior to participation, in line with the Declaration of Helsinki.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes